News
News releases on November 7, 2024, page 15
Every news release public companies put out on November 7, 2024 (UTC): 1,682 news releases, newest first. Open any release to read it.
Comstock Reports Third Quarter 2024 Results
Comstock Holding Companies, Inc. · Nov 7, 2024
ComEd Receives National Recognition for Two Energy Efficiency Programs that Help Customers Save Money and Energy
Exelon Corporation · Nov 7, 2024
Collegium Reports Record Third Quarter 2024 Financial Results
Collegium Pharmaceutical, Inc. · Nov 7, 2024
Collegium Appoints Vikram Karnani as Chief Executive Officer
Collegium Pharmaceutical, Inc. · Nov 7, 2024
Cognyte to Participate in the Needham Virtual Infrastructure, Data Analytics Software & Cloud Communications Conference
Cognyte Software Ltd. · Nov 7, 2024
Cogent Communications Reports Third Quarter 2024 Results and Increases its Regular Quarterly Dividend on its Common Stock
Cogent Communications Holdings, Inc. · Nov 7, 2024
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results
Co-Diagnostics, Inc. · Nov 7, 2024
CME Group Announces Winners of the 21st Annual University Trading Challenge
CME Group Inc. · Nov 7, 2024
CME Group Announces Employment Agreement Extension for Chairman and Chief Executive Officer Terry Duffy
CME Group Inc. · Nov 7, 2024
CMCT Announces Close of Co-Investment at Premier Los Angeles Multifamily Property
Creative Media · Nov 7, 2024
ClearPoint Neuro Reports Third Quarter 2024 Results
ClearPoint Neuro Inc. · Nov 7, 2024
Clearfield Reports Fiscal Fourth Quarter and Full Year 2024 Results
Clearfield, Inc. · Nov 7, 2024
Clarus Reports Third Quarter 2024 Results
Clarus Corporation · Nov 7, 2024
Cisco and the OECD: Building the World's First Full Picture of Digital Well-being
Cisco Systems, Inc. · Nov 7, 2024
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Cingulate Inc. · Nov 7, 2024
Cineverse to Report Second Quarter Fiscal 2025 Financial Results on Thursday, November 14, 2024
Cineverse Corp. · Nov 7, 2024
Churchill Downs Incorporated Opens The Rose Gaming Resort in Northern Virginia
Churchill Downs, Incorporated · Nov 7, 2024
ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
Niagen Bioscience, Inc. · Nov 7, 2024
Chicago Atlantic Real Estate Finance Announces Third Quarter 2024 Financial Results
Chicago Atlantic Real Estate Finance, Inc. · Nov 7, 2024
Chicago Atlantic BDC, Inc. Reports Third Quarter 2024 Financial Results
Chicago Atlantic BDC, Inc. · Nov 7, 2024
Ceva, Inc. Announces Third Quarter 2024 Financial Results
CEVA, Inc. · Nov 7, 2024
Ceva, Inc. Announces Expansion of Existing Share Repurchase Program
CEVA, Inc. · Nov 7, 2024
Cerence to Announce Fiscal Fourth Quarter Results on November 21, 2024
Cerence Inc. · Nov 7, 2024
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
Celularity Inc. · Nov 7, 2024
Cellectar Selected to Present New Data from Phase 2 CLOVER-WaM Study in Oral Session at ASH 2024
Cellectar Biosciences, Inc. · Nov 7, 2024
Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call
Celcuity Inc. · Nov 7, 2024
Castor Maritime Inc. Reports Net Income of $2.8 Million for the Three Months Ended September 30, 2024 and Net income of $48.0 Million for...
Castor Maritime Inc. · Nov 7, 2024
Castle Biosciences Surpasses 25,000 Test Reports Delivered for its TissueCypher® Barrett’s Esophagus Test
Castle Biosciences, Inc. · Nov 7, 2024
Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Cartesian Therapeutics, Inc. · Nov 7, 2024
CarGurus Announces Third Quarter 2024 Results
CarGurus, Inc. · Nov 7, 2024
Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update
Cardiff Oncology, Inc. · Nov 7, 2024
Canterbury Park Holding Corporation Reports 2024 Third Quarter Results
Canterbury Park Holding Corporation · Nov 7, 2024
Cantaloupe, Inc. Reports First Quarter Fiscal Year 2025 Financial Results
Cantaloupe, Inc. · Nov 7, 2024
Canadian Solar Schedules Third Quarter 2024 Earnings Conference Call for December 5
Canadian Solar Inc. · Nov 7, 2024
Cal-Maine Foods, Inc. to Participate in Stephens 2024 Annual Investment Conference
Cal-Maine Foods, Inc. · Nov 7, 2024
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
CalciMedica, Inc. · Nov 7, 2024
Caesars Virginia Opens Dec. 12, 2024
Caesars Entertainment, Inc. · Nov 7, 2024
Cadrenal Therapeutics provides third-quarter Corporate update
Cadrenal Therapeutics, Inc. · Nov 7, 2024
Brunswick Exploration Significantly Expands its Holdings in Greenland Following Lithium Discovery
Brunswick Exploration, Inc. · Nov 7, 2024
Brilliant Earth Reports Third Quarter 2024 Results
Brilliant Earth Group, Inc. · Nov 7, 2024
Brighthouse Financial Announces Third Quarter 2024 Results
Brighthouse Financial, Inc. · Nov 7, 2024
Brenmiller Energy Targets Decades High Demand For TES Technology
Brenmiller Energy Ltd · Nov 7, 2024
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
Boundless Bio, Inc. · Nov 7, 2024
Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at S...
Bolt Biotherapeutics, Inc. · Nov 7, 2024
Blink Charging announces third quarter 2024 results
Blink Charging Co. · Nov 7, 2024
BlackLine Announces the Planned Retirement of Chief Financial Officer and Names Successor
BlackLine, Inc. · Nov 7, 2024
Bitech Technologies Appoints Montgomery Bannerman to Board of Directors
Black Titan Corp · Nov 7, 2024
Bionomics to Present at the 2024 CNS Summit
Neuphoria Therapeutics Inc. · Nov 7, 2024
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024
Bionano Genomics, Inc. · Nov 7, 2024
BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress
BioAtla, Inc. · Nov 7, 2024
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
BioAge Labs, Inc. · Nov 7, 2024
Bentley Systems Announces Third Quarter 2024 Results
Bentley Systems, Incorporated · Nov 7, 2024
BEN Announces Date of Third Quarter 2024 Financial Results Conference Call
Brand Engagement Network Inc. · Nov 7, 2024
Bel Fuse Announces Upcoming Investor Conference Schedule for November 2024
Bel Fuse Inc. · Nov 7, 2024
Backblaze Announces Record Adjusted EBITDA Margin as Part of Third Quarter 2024 Financial Results
Backblaze, Inc. · Nov 7, 2024
Aya Gold & Silver Commences Processing of Ore at Zgounder
Aya Gold & Silver Inc. · Nov 7, 2024
Axon reports Q3 2024 revenue of $544 million, up 32% year over year, raises outlook
Axon Enterprise, Inc. · Nov 7, 2024
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
Axogen, Inc. · Nov 7, 2024
AVITA Medical Reports Third Quarter Financial Results
Avita Medical, Inc. · Nov 7, 2024
Avidity Biosciences Reports Third Quarter 2024 Financial Results and Recent Highlights
Atrium Therapeutics, Inc. · Nov 7, 2024
AvePoint Announces Third Quarter 2024 Financial Results
AvePoint, Inc. · Nov 7, 2024
Aveanna Healthcare Holdings Announces Third Quarter 2024 Financial Results and Revised 2024 Outlook
Aveanna Healthcare Holdings Inc. · Nov 7, 2024
Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
Avalo Therapeutics, Inc. · Nov 7, 2024
authID Reports Financial and Operating Results for the Third Quarter Ended September 30, 2024
authID Inc. · Nov 7, 2024
Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring t...
Aurinia Pharmaceuticals Inc · Nov 7, 2024
Aurinia Pharmaceuticals Appoints Craig Johnson to Board of Directors to Support Next Phase of Growth
Aurinia Pharmaceuticals Inc · Nov 7, 2024
AudioEye Launches Accessibility Protection Status, Setting a New Industry Standard in Compliance
AudioEye, Inc. · Nov 7, 2024
aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate Update
aTyr Pharma, Inc. · Nov 7, 2024
AtriCure to Participate in the Stifel 2024 Healthcare Conference
AtriCure, Inc. · Nov 7, 2024
Atlanticus Reports Third Quarter 2024 Financial Results
Atlanticus Holdings Corporation · Nov 7, 2024
Atea Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
Atea Pharmaceuticals, Inc. · Nov 7, 2024
Astrana Health, Inc. Reports Third Quarter 2024 Results
Astrana Health Inc. · Nov 7, 2024
Astec to participate in Baird’s 2024 Global Industrial Conference
Astec Industries, Inc. · Nov 7, 2024
Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates
Assembly Biosciences, Inc. · Nov 7, 2024
ARRAY Technologies, Inc. Reports Financial Results for the Third Quarter 2024 – Delivers exceptional gross margin growth and continued op...
Array Technologies, Inc. · Nov 7, 2024
Arq Reports Third Quarter 2024 Results
Arq, Inc. · Nov 7, 2024
Armlogi Announces New 480,000 Square Foot Warehouse Lease in Ontario, CA
Armlogi Holding Corp. · Nov 7, 2024
ARKO Corp. Reports Third Quarter 2024 Results
ARKO Corp. · Nov 7, 2024
Arhaus Reports Third Quarter 2024 Results
Arhaus, Inc. · Nov 7, 2024
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
Arcturus Therapeutics Holdings Inc. · Nov 7, 2024
Arch Capital Group Ltd. Announces Special Cash Dividend of $1.9 Billion and Senior Executive Promotions
Arch Capital Group Ltd. · Nov 7, 2024
Aqua Metals to Announce Third Quarter 2024 Financial Results and Host Investor Conference Call on November 14, 2024
Aqua Metals, Inc. · Nov 7, 2024
Aptevo Therapeutics Reports 3Q 2024 Financial Results and Provides a Business Update
Aptevo Therapeutics Inc. · Nov 7, 2024
Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Aprea Therapeutics, Inc. · Nov 7, 2024
Applied Optoelectronics Reports Third Quarter 2024 Results
Applied Optoelectronics, Inc. · Nov 7, 2024
Appian Announces Third Quarter 2024 Financial Results
Appian Corporation · Nov 7, 2024
AngloGold Ashanti Q3 2024 Earnings Release for the Three Months and Nine Months Ended 30 September 2024
AngloGold Ashanti PLC · Nov 7, 2024
Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results
Amylyx Pharmaceuticals, Inc. · Nov 7, 2024
Amplitude Announces Third Quarter 2024 Financial Results
Amplitude, Inc. · Nov 7, 2024
Americas Gold and Silver Reports Q3-2024 Results; Paul Huet Appointed CEO
Americas Gold and Silver Corporation · Nov 7, 2024
American Home Shield Launches New App
Frontdoor, Inc. · Nov 7, 2024
ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update
ALX Oncology Holdings Inc. · Nov 7, 2024
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
Alvotech · Nov 7, 2024
Alto Ingredients Publishes its Annual Sustainability Report
Alto Ingredients, Inc. · Nov 7, 2024
Altius Minerals Reports Q3 2024 Attributable Royalty Revenue of $16.6M and Adjusted Earnings(1) of $2.6M
Altius Minerals Corporation · Nov 7, 2024
Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity
Altimmune, Inc. · Nov 7, 2024
Allogene Therapeutics Reports Third Quarter 2024 Financial Results and Business Update
Allogene Therapeutics, Inc. · Nov 7, 2024
Allogene Therapeutics Announces Positive Phase 1 Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Patients with Advance...
Allogene Therapeutics, Inc. · Nov 7, 2024
Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences
Alkermes plc · Nov 7, 2024
Aldebaran Resources Signs Option to Joint Venture Agreement with Nuton Holdings Ltd. (a Rio Tinto Venture) for the Altar Project in San J...
Aldebaran Resources Inc · Nov 7, 2024